Research and Development

Showing 15 posts of 9616 posts found.

banner_3

Free Pharmacovigilance Webinar: Just two days left to register!

November 7, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, pharmacovigilance, primevigilance

There are only two more days to register for our free pharmacovigilance webinar on 10 November, in association with PrimeVigilance. …
clinical_trials

Clinical trials and their patients: The rising costs and how to stem the loss

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials

The pharmaceutical industry has a big problem and it’s one that keeps getting worse every year – how to stop …
nice_reception

NICE approves first new drug for breast cancer in a decade

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

NICE has approved Eisai’s Halaven (eribulin) for routine treatment of sufferers of locally advanced or metastatic breast cancer that has …
bernie_2

Lily increases diabetes drug by 700% over 20 years

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Eli Lily, Humalog, diabetes

It has come to light that, over a 20 year period, Eli Lily has increased the price of its diabetes …
merck_and_co

MSD’s Alzheimer’s study could break new ground for treatment

November 3, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, MSD, clinical trials

MSD, known as Merck in North America, has published results of a Phase I trial of verubecestat. The drug is …
fda2outsideweb

FDA issues warning letter after Chinese firm impedes investigation

November 2, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing China, FDA

The US Food and Drugs Administration (FDA) has issued a Chinese firm with a warning letter after claims it intentionally …
gilead-sciences

Gilead quietly drops drugs from line up alongide Q3 results

November 2, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Abzena, Gilead, research and development

Gilead Sciences followed Pfizer in discreetly dropping a drug alongside its third quarter profit reports. The drug in question, for …

Multi Packaging Solutions wins ‘Packaging Company of the Year’

November 2, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Multi Packaging Solutions (“MPS”)(NYSE: MPSX),  a global market leader in healthcare, spirits, confectionery and media packaging, has been voted the …

Avacta joins major US cancer centre for CAR-T immunotherapy development

November 2, 2016 Research and Development Avacta, Memorial Sloan Kettering Cancer Center

Biotherapeutic and research reagent developer Avacta has announced it will collaborate with New York’s Memorial Sloan Kettering Cancer Center (MSK, …
gilead-sciences

Nimbus Therapeutics receives $200 million payment from Gilead

November 2, 2016 Research and Development Gilead Sciences, Nimbus Therapeutics, nash

Nimbus Therapeutics only signed a deal with Gilead Sciences back in April of this year and yet have already received …
ibm_web

Celgene partners with IBM for new pharmacovigilance platform

November 2, 2016 Research and Development, Sales and Marketing Celgene, Watson, ibm

IBM is set to join forces with Celgene to develop a new drug safety evaluation platform, it has emerged. Running …
valeant

Valeant looking at selling core asset to manage debt

November 2, 2016 Research and Development Takeda Pharmaceutical, Valeant pharmaceutical, salix

Valeant is rumoured to be looking into selling its Salix drugs business to Takeda Pharmaceutical, with figures floated of a …

Pfizer surprises industry by ending development of projected blockbuster

November 1, 2016 Research and Development Pfizer, cholesterol, clinical trials

Pfizer announced the news that it would no longer be developing an experimental cholesterol lowering drug. The drug had been …
marc_weeks_takeda

Takeda appoint Marc Weeks to Digital Lead role

October 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Takeda, digital

Takeda UK have appointed Marc Weeks to the newly created role of digital lead. The creation of the role comes as …

Ashfield walks away with gold at EVCOM Clarion Awards

October 31, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ashfield

The awards ceremony, held at The Seven Dials Club, Covent Garden, London on Friday 7 October, drew leading event and …
The Gateway to Local Adoption Series

Latest content